Janux Therapeutics, Inc.
(JANX - NASDAQ)
15,23 USD
📋 Profilo Aziendale

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer.

|